149 related articles for article (PubMed ID: 34933995)
1. Latin Americans and US Hispanics show differences in IBD phenotype: a systematic review with meta-analysis.
Avalos DJ; Satiya J; Contreras A; Trivedi S; Alvarado L; Dodoo C; Dwivedi AK; Zuckerman MJ
J Investig Med; 2022 Apr; 70(4):919-933. PubMed ID: 34933995
[TBL] [Abstract][Full Text] [Related]
2. Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.
Avalos DJ; Mendoza-Ladd A; Zuckerman MJ; Bashashati M; Alvarado A; Dwivedi A; Damas OM
Dig Dis Sci; 2018 Jun; 63(6):1558-1571. PubMed ID: 29594975
[TBL] [Abstract][Full Text] [Related]
3. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review.
Kotze PG; Underwood FE; Damião AOMC; Ferraz JGP; Saad-Hossne R; Toro M; Iade B; Bosques-Padilla F; Teixeira FV; Juliao-Banos F; Simian D; Ghosh S; Panaccione R; Ng SC; Kaplan GG
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):304-312. PubMed ID: 31252191
[TBL] [Abstract][Full Text] [Related]
4. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review.
Hou JK; El-Serag H; Thirumurthi S
Am J Gastroenterol; 2009 Aug; 104(8):2100-9. PubMed ID: 19471256
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study.
Damas OM; Jahann DA; Reznik R; McCauley JL; Tamariz L; Deshpande AR; Abreu MT; Sussman DA
Am J Gastroenterol; 2013 Feb; 108(2):231-9. PubMed ID: 23247580
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study.
Balderramo D; Yamamoto-Furusho J; Ponce de León E; de María J; Zubiaurre I; Pedreira S; Lis C; Brion L; de Paula JA
Gastroenterol Hepatol; 2024 Jan; 47(1):51-62. PubMed ID: 37062500
[TBL] [Abstract][Full Text] [Related]
7. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES.
Quaresma AB; Coy CSR; Damião AOMC; Kaplan GG; Kotze PG
Arq Gastroenterol; 2019; 56(3):318-322. PubMed ID: 31633732
[TBL] [Abstract][Full Text] [Related]
8. Basic epidemiology of inflammatory bowel disease in Puerto Rico.
Appleyard CB; Hernández G; Rios-Bedoya CF
Inflamm Bowel Dis; 2004 Mar; 10(2):106-11. PubMed ID: 15168809
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Inflammatory Bowel Diseases in Puerto Rico: A Health Care Claims Analysis of an Insured Population.
Torres EA; Torres-Cintron M; Velazquez S; Vendrell R; Del Valle A; Pérez CM
P R Health Sci J; 2021 Sep; 40(3):103-109. PubMed ID: 34792922
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
11. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
12. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.
Buie MJ; Quan J; Windsor JW; Coward S; Hansen TM; King JA; Kotze PG; Gearry RB; Ng SC; Mak JWY; Abreu MT; Rubin DT; Bernstein CN; Banerjee R; Yamamoto-Furusho JK; Panaccione R; Seow CH; Ma C; Underwood FE; Ahuja V; Panaccione N; Shaheen AA; Holroyd-Leduc J; Kaplan GG; ; Balderramo D; Chong VH; Juliao-Baños F; Dutta U; Simadibrata M; Kaibullayeva J; Sun Y; Hilmi I; Raja Ali RA; Paudel MS; Altuwaijri M; Hartono JL; Wei SC; Limsrivilai J; El Ouali S; Vergara BI; Dao VH; Kelly P; Hodges P; Miao Y; Li M
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2211-2221. PubMed ID: 35863682
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of inflammatory bowel disease in South America: A systematic review.
Selvaratnam S; Gullino S; Shim L; Lee E; Lee A; Paramsothy S; Leong RW
World J Gastroenterol; 2019 Dec; 25(47):6866-6875. PubMed ID: 31885427
[TBL] [Abstract][Full Text] [Related]
14. Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean.
Yamamoto-Furusho JK; Parra-Holguín NN; Juliao-Baños F; Puentes F; López R; Bosques-Padilla F; Torres EA; Nieves-Jimenéz H; Veitia-Velásquez GR; Jara-Alba ML; Bautista S; Piñol-Jimenez FN; Salgado-Rosado P; Villa-Ovalles KC; Abreu-Martinez YA; Borges Z; Davila-Bedoya S; Otoya-Moreno G; Iadé-Vergara B;
Medicine (Baltimore); 2022 Jan; 101(3):e28624. PubMed ID: 35060539
[TBL] [Abstract][Full Text] [Related]
15. Demographic and Clinical Characteristics of a Predominantly Hispanic Population with Inflammatory Bowel Disease on the US-Mexico Border.
Mendoza Ladd A; Jia Y; Yu C; Elhanafi S; Dwivedi A; Liu J; Song G; Hall M; Zuckerman MJ
South Med J; 2016 Dec; 109(12):792-797. PubMed ID: 27911976
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
Nguyen GC; Torres EA; Regueiro M; Bromfield G; Bitton A; Stempak J; Dassopoulos T; Schumm P; Gregory FJ; Griffiths AM; Hanauer SB; Hanson J; Harris ML; Kane SV; Orkwis HK; Lahaie R; Oliva-Hemker M; Pare P; Wild GE; Rioux JD; Yang H; Duerr RH; Cho JH; Steinhart AH; Brant SR; Silverberg MS
Am J Gastroenterol; 2006 May; 101(5):1012-23. PubMed ID: 16696785
[TBL] [Abstract][Full Text] [Related]
17. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil.
Zaltman C; Parra RS; Sassaki LY; Santana GO; Ferrari MLA; Miszputen SJ; Amarante HMBS; Kaiser Junior RL; Flores C; Catapani WR; Parente JML; Bafutto M; Ramos O; Gonçalves CD; Guimaraes IM; da Rocha JJR; Feitosa MR; Feres O; Saad-Hossne R; Penna FGC; Cunha PFS; Gomes TN; Nones RB; Faria MAG; Parente MPPD; Scotton AS; Caratin RF; Senra J; Chebli JM
World J Gastroenterol; 2021 Jan; 27(2):208-223. PubMed ID: 33510560
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease characteristics in Hispanic children in Texas.
Hattar LN; Abraham BP; Malaty HM; Smith EO; Ferry GD
Inflamm Bowel Dis; 2012 Mar; 18(3):546-54. PubMed ID: 21456045
[TBL] [Abstract][Full Text] [Related]
19. Hispanics and inflammatory bowel disease.
Lattimer LD; Chandler MB; Borum ML
Inflamm Bowel Dis; 2015 May; 21(5):1214-8. PubMed ID: 25581831
[TBL] [Abstract][Full Text] [Related]
20. High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina.
Balderramo D; Trakal J; Herrera Najum P; Vivas M; Gonzalez R; Benavidez A; López Villa D; Daino D; Raiden K; Germán A; Corzo MA; Ponce de León J; Ferrer L; Germán C; Bálzola S; Idoeta A; Zárate F; Defagó MR;
Dig Liver Dis; 2021 Jul; 53(7):852-857. PubMed ID: 33531211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
